4,427
Views
29
CrossRef citations to date
0
Altmetric
Reviews

Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Benjamín Diethelm-Varela, Jorge A Soto, Claudia A Riedel, Susan M Bueno & Alexis M Kalergis. (2023) New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus. Infection and Drug Resistance 16, pages 2061-2074.
Read now
Brian J. Booth, Boopathy Ramakrishnan, Kristin Narayan, Andrew M. Wollacott, Gregory J. Babcock, Zachary Shriver & Karthik Viswanathan. (2018) Extending human IgG half-life using structure-guided design. mAbs 10:7, pages 1098-1110.
Read now
Esther Shuyi Gan, Donald Heng Rong Ting & Kuan Rong Chan. (2017) The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis. Expert Review of Anti-infective Therapy 15:2, pages 111-119.
Read now

Articles from other publishers (25)

Sara Trzos, Paweł Link-Lenczowski & Ewa Pocheć. (2023) The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy. Frontiers in Immunology 14.
Crossref
Tulika Singh, Kwan-Ki Hwang, Andrew S. Miller, Rebecca L. Jones, Cesar A. Lopez, Sarah J. Dulson, Camila Giuberti, Morgan A. Gladden, Itzayana Miller, Helen S. Webster, Joshua A. Eudailey, Kan Luo, Tarra Von Holle, Robert J. Edwards, Sarah Valencia, Katherine E. Burgomaster, Summer Zhang, Jesse F. Mangold, Joshua J. Tu, Maria Dennis, S. Munir Alam, Lakshmanane Premkumar, Reynaldo Dietze, Theodore C. Pierson, Eng Eong Ooi, Helen M. Lazear, Richard J. Kuhn, Sallie R. Permar & Mattia Bonsignori. (2022) A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization. Cell 185:25, pages 4826-4840.e17.
Crossref
William R. Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F. Carroll, Bruce A. Keyt & Lila M. Strohl. (2022) Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants. BioDrugs 36:3, pages 231-323.
Crossref
Tal Noy-Porat, Avishay Edri, Ron Alcalay, Efi Makdasi, David Gur, Moshe Aftalion, Yentl Evgy, Adi Beth-Din, Yinon Levy, Eyal Epstein, Olga Radinsky, Ayelet Zauberman, Shirley Lazar, Shmuel Yitzhaki, Hadar Marcus, Angel Porgador, Ronit Rosenfeld & Ohad Mazor. (2021) Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies. Antibodies 10:4, pages 45.
Crossref
Andrew T. Lucas, Amber Moody, Allison N. Schorzman & William C. Zamboni. (2021) Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective. Antibodies 10:3, pages 30.
Crossref
Kuttuvan Valappil Sajna & Siya Kamat. (2021) Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2. Cytotherapy 23:2, pages 101-110.
Crossref
Xiaojie Yu & Mark S. Cragg. (2020) Engineered antibodies to combat viral threats. Nature 588:7838, pages 398-399.
Crossref
Dun-Xian Tan & Ruediger Hardeland. (2020) Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19. Molecules 25:19, pages 4410.
Crossref
Fabian Junker, John Gordon & Omar Qureshi. (2020) Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation. Frontiers in Immunology 11.
Crossref
Darren Z. L. Mok & Kuan Rong Chan. (2020) The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines. Viruses 12:5, pages 520.
Crossref
Ge YANG, Shi-Miao HAN, Li-Ping ZHAO, Chao ZHU, Yuan-Yu HUANG & Feng QU. (2020) Screening of Aptamer for Human IgG Fc Fragment by Capillary Electrophoresis-Systematic Evolution of Ligands by Exponential Enrichment. Chinese Journal of Analytical Chemistry 48:5, pages 601-607.
Crossref
Amar K. Garg, Rajat Desikan & Narendra M. Dixit. (2019) Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response. Cell Reports 29:12, pages 3946-3957.e5.
Crossref
Prathap Kumar Mahalingaiah, Rita Ciurlionis, Kenneth R. Durbin, Ronnie L. Yeager, Binu K. Philip, Bhupinder Bawa, Srinivasa R. Mantena, Brian P. Enright, Michael J. Liguori & Terry R. Van Vleet. (2019) Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates. Pharmacology & Therapeutics 200, pages 110-125.
Crossref
Mohammad Doosti, Mohammadreza Nassiri, Khadijeh Nasiri, Mojtaba Tahmoorespur & Saeed Zibaee. (2019) Immunogenic evaluation of FMD virus immuno-dominant epitopes coupled with IL-2/FcIgG in BALB/c mice. Microbial Pathogenesis 132, pages 30-37.
Crossref
Kashyap R. Patel, Jacob T. Roberts & Adam W. Barb. (2019) Multiple Variables at the Leukocyte Cell Surface Impact Fc γ Receptor-Dependent Mechanisms. Frontiers in Immunology 10.
Crossref
Cheng Li, Yang Wang, Tiantian Liu, Matthias Niklasch, Ke Qiao, Sarah Durand, Li Chen, Mifang Liang, Thomas F. Baumert, Shuping Tong, Michael Nassal, Yu-Mei Wen & Yong-Xiang Wang. (2019) An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion. Antiviral Research 162, pages 118-129.
Crossref
Yuri L. Dorokhov, Ekaterina V. Sheshukova & Tatiana V. Komarova. 2019. Plant Biotechnology: Progress in Genomic Era. Plant Biotechnology: Progress in Genomic Era 543 581 .
Philipp A. Ilinykh, Rodrigo I. Santos, Bronwyn M. Gunn, Natalia A. Kuzmina, Xiaoli Shen, Kai Huang, Pavlo Gilchuk, Andrew I. Flyak, Patrick Younan, Galit Alter, James E. Crowe & Alexander Bukreyev. (2018) Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. PLOS Pathogens 14:8, pages e1007204.
Crossref
Natalia A. Kuzmina, Patrick Younan, Pavlo Gilchuk, Rodrigo I. Santos, Andrew I. Flyak, Philipp A. Ilinykh, Kai Huang, Ndongala M. Lubaki, Palaniappan Ramanathan, James E. CroweJr.Jr. & Alexander Bukreyev. (2018) Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. Cell Reports 24:7, pages 1802-1815.e5.
Crossref
Katharina Arens, Christodoulos Filippis, Helen Kleinfelder, Arthur Goetzee, Gabriele Reichmann, Peter Crauwels, Zoe Waibler, Katrin Bagola & Ger van Zandbergen. (2018) Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Leishmania Infection of Human Macrophages. Frontiers in Immunology 9.
Crossref
Haiyan Sun, Qiang Chen & Huafang Lai. (2017) Development of Antibody Therapeutics against Flaviviruses. International Journal of Molecular Sciences 19:1, pages 54.
Crossref
Melissa Ghulam-Smith, Alex Olson, Laura F. White, Charles S. Chasela, Sascha R. Ellington, Athena P. Kourtis, Denise J. Jamieson, Gerald Tegha, Charles M. van der Horst & Manish Sagar. (2017) Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity. mBio 8:5.
Crossref
James Duehr, Teddy John Wohlbold, Lisa Oestereich, Veronika Chromikova, Fatima Amanat, Madhusudan Rajendran, Sergio Gomez-Medina, Ignacio Mena, Benjamin R. tenOever, Adolfo García-Sastre, Christopher F. Basler, Cesar Munoz-Fontela & Florian Krammer. (2017) Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model. Journal of Virology 91:16.
Crossref
Adam Seidelin Hey. 2017. Recombinant Antibodies for Infectious Diseases. Recombinant Antibodies for Infectious Diseases 265 294 .
Y. L. Dorokhov, E. V. Sheshukova, E. N. Kosobokova, A. V. Shindyapina, V. S. Kosorukov & T. V. Komarova. (2016) Functional role of carbohydrate residues in human immunoglobulin G and therapeutic monoclonal antibodies. Biochemistry (Moscow) 81:8, pages 835-857.
Crossref